Paul Baas, MD, PhD, discusses the benefits of immunotherapy in subpopulations of patients with mesothelioma.
Paul Baas, MD, PhD
Advertisement
Articles by Paul Baas, MD, PhD
Paul Baas, MD, PhD, discusses recent updates in immuno-oncology within the field of mesothelioma.
Dr. Paul Baas from the Netherlands Cancer Institute on the Standard of Care for Mesothelioma Patients
Advertisement
Latest Updated Articles
Dr. Baas on the Standard of Care for Mesothelioma PatientsSeptember 6th 2011
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
SERENA-6 Meets PFS2 End Point With Early Switch to Camizestrant in ER+/HER2-Negative, ESR1-Mutated Advanced Breast Cancer
5